Highlights and Quick Summary
- Current Revenue (Deferred) for the quarter ending December 31, 2022 was $25 Thousand (a -67.11% decrease compared to previous quarter)
- Year-over-year quarterly Current Revenue (Deferred) decreased by -99.06%
- Annual Current Revenue (Deferred) for 2022 was $25 Thousand (a -98.32% decrease from previous year)
- Annual Current Revenue (Deferred) for 2021 was $1.49 Million (a -46.79% decrease from previous year)
- Annual Current Revenue (Deferred) for 2020 was $2.8 Million (a -50.85% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Revenue (Deferred) of Precigen, Inc.
Most recent Current Revenue (Deferred)of PGEN including historical data for past 10 years.Interactive Chart of Current Revenue (Deferred) of Precigen, Inc.
Precigen, Inc. Current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $0.03 | $0.08 | $0.16 | $2.67 | $0.03 |
2021 | $1.49 | $3.69 | $3.28 | $3.85 | $1.49 |
2020 | $2.8 | $4.14 | $6.59 | $11.14 | $2.8 |
2019 | $5.7 | $12.76 | $16.59 | $17.15 | $5.7 |
2018 | $11.09 | $38.04 | $39.82 | $38.38 | $11.09 |
2017 | $42.87 | $48.29 | $47.66 | $50.33 | $42.87 |
2016 | $53.36 | $54.94 | $53.86 | $37.7 | $53.36 |
2015 | $35.37 | $32.01 | $28.74 | $17.29 | $35.37 |
2014 | $16.52 | $13.95 | $10.71 | $10.94 | $16.52 |
2013 | – | $7.79 | $7.4 | $8.27 | $7.79 |
2012 | – | – | – | – | $9.96 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology